Coloplast A/S
Stock Forecast, Prediction & Price Target
Coloplast A/S Financial Estimates
Coloplast A/S Revenue Estimates
Coloplast A/S EBITDA Estimates
Coloplast A/S Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 9/30/2022 | 9/30/2023 | 9/30/2024 | 9/30/2025 | 9/30/2026 | 9/30/2027 | 9/30/2028 |
Revenue
% change YoY
| $22.57B N/A | $24.5B 8.50% | $27.03B 10.32% | Avg: $28.94B Low: $28.94B High: $28.94B avg. 7.07% | Avg: $31.40B Low: $31.40B High: $31.40B avg. 8.51% | Avg: $33.99B Low: $33.99B High: $33.99B avg. 8.24% | Avg: $36.81B Low: $36.81B High: $36.81B avg. 8.29% |
Net Income
% change YoY
| $4.70B N/A | $4.78B 1.63% | $5.05B 5.62% | Avg: $585.66M Low: $585.66M High: $585.66M avg. -88.40% | Avg: $651.23M Low: $651.23M High: $651.23M avg. 11.19% | Avg: $738.86M Low: $738.86M High: $738.86M avg. 13.45% | Avg: $858.36M Low: $858.36M High: $858.36M avg. 16.17% |
EBITDA
% change YoY
| $7.86B N/A | $7.81B -0.64% | $8.48B 8.53% | Avg: $10.01B Low: $10.01B High: $10.01B avg. 18.08% | Avg: $10.86B Low: $10.86B High: $10.86B avg. 8.51% | Avg: $11.76B Low: $11.76B High: $11.76B avg. 8.24% | Avg: $12.73B Low: $12.73B High: $12.73B avg. 8.29% |
EPS
% change YoY
| $22.15 N/A | $22.21 0.27% | $22.46 1.12% | Avg: $2.72 Low: $2.72 High: $2.72 avg. -87.89% | Avg: $3.02 Low: $3.02 High: $3.02 avg. 11.19% | Avg: $3.43 Low: $3.43 High: $3.43 avg. 13.45% | Avg: $3.98 Low: $3.98 High: $3.98 avg. 16.17% |
Operating Expenses
% change YoY
| $8.61B N/A | $9.48B 10.02% | $10.94B 15.45% | Avg: $9.72B Low: $9.72B High: $9.72B avg. -11.20% | Avg: $10.55B Low: $10.55B High: $10.55B avg. 8.51% | Avg: $11.42B Low: $11.42B High: $11.42B avg. 8.24% | Avg: $12.36B Low: $12.36B High: $12.36B avg. 8.29% |
FAQ
What is Coloplast A/S stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -11.89% in 2025-2028.
We have gathered data from 2 analysts. Their low estimate is 585.66M, average is 585.66M and high is 585.66M.
What is Coloplast A/S stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 8.03% in 2025-2028.
We have gathered data from N/A analysts. Their low revenue estimate is $28.94B, average is $28.94B and high is $28.94B.
What is Coloplast A/S stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of -11.76% in 2025-2028.
We have gathered data from 2 analysts. Their low earnings per share estimate is $2.72, average is $2.72 and high is $2.71.